OUE Lippo Healthcare Limited provided consolidated earnings guidance for the second half year and full year ended 31 December 2022. The expected net loss after non-controlling interest for second half 2022 is mainly attributable to net fair value losses relating to investments properties and impairment of investment in associate and joint ventures.

The company expects to report an overall net profit after non- controlling interest in respect of the Group for the full year ended 31 December 2022.